Axsome Therapeutics Inc.

NASDAQ: AXSM · Real-Time Price · USD
109.20
0.45 (0.41%)
At close: Aug 15, 2025, 3:59 PM
108.99
-0.19%
After-hours: Aug 15, 2025, 04:57 PM EDT

Axsome Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-14.11 -15.11 -15.86 -10.53
PEG Ratio
-1.03 -1.79 -0.45 -0.39
PS Ratio
10.51 13.36 62.67 n/a
PB Ratio
71.10 18.93 28.62 -3.47
P/FCF Ratio
-31.5 -24.82 -26.75 -13.09
P/OCF Ratio
-31.57 -24.92 -26.91 -13.13
OCF/S Ratio
-0.33 -0.54 -2.33 n/a
Debt / Equity Ratio
3.38 0.98 0.86 -0.12
Quick Ratio
2.04 3.52 2.50 3.75
Current Ratio
2.11 3.63 2.54 3.75
Asset Turnover
0.68 0.46 0.15 n/a
Interest Coverage
-42.71 -35.93 -24.06 -21.89
Return on Equity
-5.04 -1.25 -1.81 0.33
Return on Assets
-0.51 -0.41 -0.6 0.40
Return on Invested Capital
-0.82 -0.52 -0.79 -1.91
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.91 0.90 0.90 n/a
Net Profit Margin
-0.74 -0.88 -3.95 n/a
Pretax Profit Margin
-0.74 -0.88 -3.74 n/a
Operating Profit Margin
-0.73 -0.86 -3.53 n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.71 -0.83 -3.48 n/a